Zedira Transglutaminase Services

Based on our profound expertise in transglutaminase, celiac disease and related fields, Zedira supports your R&D-work on a fee-for-service base.

Service categories include, but are not limited to:

•    Determination of microbial transglutaminase activity in food-preparations
•    Determination of gluten / gliadin content in food and food preparations
•    Production of transglutaminases from animal species (if not already listed in our product catalogue)
•    Modification of transglutaminases (biotin, fluorescent labels, …)
•    Development of transglutaminase assays for customer specific applications
•    Determination of human and animal transglutaminase inhibition in drug development
•    Organic synthesis of small transglutaminase related molecules (e.g. substrates, inhibitors).
    Whatever you need - a product or a service around transglutaminase or related fields, please do not hesitate to contact us.
  Phone:   +49 6151 3251-00
  E-mail:   contact@zedira.com
  • News  

    • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
    • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Blog

  • Events  

    • Transglutaminases in Medicine

      03.08.2017 - 05.08.2017
      Debrecen, Hungary

    • 17th International Celiac Disease Symposium

      08.09.2017 - 10.09.2017
      New Delhi, India

    • NLSDays 2017

      12.09.2017 - 14.09.2017
      Malmö, Sweden

    • BIO-Europe

      06.11.2017 - 08.11.2017
      Berlin, Germany

    • MEDICA

      13.11.2017 - 16.11.2017
      Düsseldorf, Germany

    • Gordon Research Conference on: Transglutaminases in Human Disease Processes

      16.06.2018 - 17.06.2018
      Les Diablerets, Switzerland